Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

631
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
631
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.9K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.9K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

1.6K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K
Cancer Vaccines01:30

Cancer Vaccines

483
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
483

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inactivation of SERCA2 at Cys674 induces skeletal muscle atrophy by activating the TGFβ/Smad-S100a4 axis to promote inflammation.

Redox biology·2026
Same author

An electrochemical sensing platform based on targeted paired binding for biomarker detection in human serum samples.

Biosensors & bioelectronics·2026
Same author

CAV1 up-regulated by peste des petits ruminants virus nucleocapsid protein impairs type I IFN response by cholesterol synthesis.

Veterinary microbiology·2026
Same author

Real-time identification of aetiology in patients able to undergo transoesophageal echocardiography with non-traumatic out-of-hospital cardiac arrest in China: a prospective, single-centre exploratory study.

Emergency medicine journal : EMJ·2026
Same author

STARD10 promotes progression of HER2+ breast cancer and intracellular lipid metabolism via the cAMP/PKA/CREB1 signaling axis.

Cancer biology & therapy·2026
Same author

Glycosphingolipids regulate phosphatidylserine transport machinery that operates at ER-PM contact sites.

Nature communications·2026

Related Experiment Video

Updated: Aug 20, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.8K

Harnessing natural killer cells to develop next-generation cellular immunotherapy.

Siyao Liu1, Kaycee Nguyen1, Dongyong Park1

  • 1Center for Translational Cancer Research, Institute of Biosciences and Technology Texas A&M University Houston Texas USA.

Chronic Diseases and Translational Medicine
|November 24, 2022
PubMed
Summary

Chimeric antigen receptor natural killer (CAR-NK) cells offer a safer and more effective cancer immunotherapy than CAR-T cells. Preclinical studies show CAR-NK cells can eliminate hematological and solid tumors.

Keywords:
CAR‐NK immunotherapycancerchimeric antigen receptor (CAR)natural killer (NK) cells

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

963
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

816

Related Experiment Videos

Last Updated: Aug 20, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.8K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

963
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

816

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Cellular immunotherapy utilizes engineered immune cells like T cells, macrophages, or NK cells to combat cancer.
  • Chimeric antigen receptor T (CAR-T) cell therapy is established for hematological malignancies.
  • CAR-NK cells present an alternative with potential advantages over CAR-T cells.

Purpose of the Study:

  • To review the design principles of CAR-NK cells.
  • To summarize recent advancements in CAR-NK cell preclinical and clinical research.
  • To identify and address challenges in CAR-NK therapy.

Main Methods:

  • Review of preclinical data on CAR-NK cell efficacy in animal models.
  • Analysis of ongoing and completed clinical trials involving CAR-NK cells.
  • Discussion of immune cell engineering principles relevant to CAR-NK development.

Main Results:

  • CAR-NK cells demonstrate significant therapeutic potential against both hematological malignancies and solid tumors in preclinical settings.
  • CAR-NK therapy exhibits enhanced safety profiles, reduced graft-versus-host disease risk, and fewer side effects compared to CAR-T cells.
  • Preclinical evidence supports the amplified antitumor efficacy of CAR-NK cells.

Conclusions:

  • CAR-NK cell therapy is a promising next-generation immunotherapy with broad applicability.
  • Overcoming current roadblocks in CAR-NK therapy is crucial for clinical translation.
  • Continued progress in immune cell engineering will advance CAR-NK cell therapy's role in cancer treatment.